Company profile

RoukenBio

We provide drug developers with high-quality data to give them the confidence to take their drug discovery forward.

Industry
Biotechnology Research
Employees
113
Headquarters
Motherwell, Scotland
Founded
2015
LinkedIn followers
11,872
Office locations
1

RoukenBio company summary

RoukenBio is a company in the Biotechnology Research industry, headquartered in Motherwell, Scotland, founded in 2015. On LinkedIn the company has around 113 employees and 11,872 followers. Its listed specialties include Bioassays, ADCC, mAbs, ADCs, Bi-specifics.

What technology does RoukenBio use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About RoukenBio

RoukenBio – CRO redefined. RoukenBio takes its tagline seriously - disrupting the traditional CRO model with a collaborative, personalised approach to drug discovery. With customers in over 27 countries, RoukenBio aims to become the most trusted research partner to biotherapeutic innovators globally. Backed by brilliant minds, RoukenBio offers a range of in vitro drug discovery services with specialist expertise across human immunology, bioanalytical, cell line engineering, molecular biology, bioassay development and safety and efficacy assessments. RoukenBio partners with therapeutic developers from early discovery, through IND-enabling pivotal data studies, to ‘GMP-ready’ potency assay creation. Working across inflammation, auto-immunity, immuno-oncology and oncology, their team focuses on novel and emerging therapeutic classes including antibodies, cell therapies, nanoparticles, small molecules, protein degraders, peptides, recombinant proteins, vaccines, antibody drug conjugates and more. RoukenBio embraces change and drives innovation with unique services, like the customisable inducible cell line platform, IndEx-2, to stay ahead of the curve. RoukenBio’s assay solutions recreate disease state pathologies as faithfully as possible, and combined with a thought-partner approach to research collaborations, the RoukenBio team uses their scientific empathy to propel their customer’s therapeutic development projects forward.

Specialties

BioassaysADCCmAbsADCsBi-specificsBiosimilarsImmuno-oncologyMethod developmentt cell activationt cellstumor microenvironmentTDCCcell line developmentcheckpoint inhibitorsimmunologyimmunotherapeuticsantibodytherapeuticsimmune cell engagersCROservicesbiologicsNK cellsmacrophagesdendritic cellsdrug developmentCAR-Tdrug discoverycell therapyTregs

Where is RoukenBio located?

RoukenBio lists 1 location.

Motherwell, Scotland ML1 3ST, GBHQ
Antibody Analytics Discovery Centre

Compare companies similar to RoukenBio

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
RoukenBio
rouken.bio
Biotechnology Research1132015Motherwell, Scotland
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about RoukenBio

What does RoukenBio do?

RoukenBio – CRO redefined. RoukenBio takes its tagline seriously - disrupting the traditional CRO model with a collaborative, personalised approach to drug discovery. With customers in over 27 countries, RoukenBio aims to become the most trusted research partner to biotherapeutic innovators globally. Backed by brilliant minds, RoukenBio offers a range of in vitro drug discovery services with specialist expertise across human immunology, bioanalytical, cell line engineering, molecular biology, bioassay development and safety and efficacy assessments. RoukenBio partners with therapeutic developers from early discovery, through IND-enabling pivotal data studies, to ‘GMP-ready’ potency assay creation. Working across inflammation, auto-immunity, immuno-oncology and oncology, their team focuses on novel and emerging therapeutic classes including antibodies, cell therapies, nanoparticles, small molecules, protein degraders, peptides, recombinant proteins, vaccines, antibody drug conjugates and more. RoukenBio embraces change and drives innovation with unique services, like the customisable inducible cell line platform, IndEx-2, to stay ahead of the curve. RoukenBio’s assay solutions recreate disease state pathologies as faithfully as possible, and combined with a thought-partner approach to research collaborations, the RoukenBio team uses their scientific empathy to propel their customer’s therapeutic development projects forward.

How many employees does RoukenBio have?

RoukenBio has around 113 employees on LinkedIn.

Where is RoukenBio headquartered?

RoukenBio is headquartered in Motherwell, Scotland.

When was RoukenBio founded?

RoukenBio was founded in 2015.

Build a lead list from companies like RoukenBio

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.